Elizabeth Robertson
Overview
Explore the profile of Elizabeth Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gharibzadeh S, Routen A, Razieh C, Zaccardi F, Lawson C, Gillies C, et al.
EClinicalMedicine
. 2025 Jan;
79:103005.
PMID: 39834716
Background: People with diabetes are at increased risk of hospitalisation, morbidity, and mortality following SARS-CoV-2 infection. Long-term outcomes for people with diabetes previously hospitalised with COVID-19 are, however, unknown. This...
2.
Ezeofor V, Anthony B, Bryning L, Casswell E, Cro S, Cornelius V, et al.
PLoS One
. 2024 Dec;
19(12):e0311158.
PMID: 39680515
Background: In the United Kingdom, it is estimated that 5,000 patients sustain eye injuries or ocular trauma requiring hospital admission annually, of which 250 patients will be permanently blinded. This...
3.
Valabhji J, Gorton T, Barron E, Safazadeh S, Earnshaw F, Helm C, et al.
Lancet Diabetes Endocrinol
. 2024 Aug;
12(9):653-663.
PMID: 39116897
Background: Randomised controlled trials have shown that total diet replacement (TDR) can lead to remission of type 2 diabetes. In 2019, the English National Health Service (NHS) committed to establishing...
4.
Ennis S, Bruce J, Sandhu H, Ratna M, Lall R, Ji C, et al.
Trials
. 2024 Jul;
25(1):495.
PMID: 39033102
Background: The SPHERe (Supervised Pulmonary Hypertension Exercise Rehabilitation) trial is a multi-centre, pragmatic, randomised controlled trial assessing the clinical and cost-effectiveness of supervised exercise rehabilitation with psychosocial and motivational support...
5.
Lopez D, Cardenas-Iniguez C, Subramaniam P, Adise S, Bottenhorn K, Badilla P, et al.
Dev Cogn Neurosci
. 2024 Jun;
68:101408.
PMID: 38924835
Background: Transparency can build trust in the scientific process, but scientific findings can be undermined by poor and obscure data use and reporting practices. The purpose of this work is...
6.
Lopez D, Cardenas-Iniguez C, Subramaniam P, Adise S, Bottenhorn K, Badilla P, et al.
medRxiv
. 2024 Jun;
PMID: 38854118
Background: Transparency can build trust in the scientific process, but scientific findings can be undermined by poor and obscure data use and reporting practices. The purpose of this work is...
7.
Robertson E, Sutcliffe J, Connor R, Heller S
Diabet Med
. 2024 Jun;
41(7):e15376.
PMID: 38837491
No abstract available.
8.
Birkenhead K, Sullivan D, Trumble C, Spinks C, Srinivasan S, Partington A, et al.
BMJ Open
. 2024 May;
14(5):e082699.
PMID: 38692720
Introduction: Familial hypercholesterolaemia (FH) is an autosomal dominant inherited disorder of lipid metabolism and a preventable cause of premature cardiovascular disease. Current detection rates for this highly treatable condition are...
9.
Charteris D, Cro S, Casswell E, Tudor Edwards R, Ezeofor V, Anthony B, et al.
Health Technol Assess
. 2023 Oct;
27(12):1-50.
PMID: 37840322
Background: Eyes sustaining open globe trauma are at high risk of severe visual impairment. Proliferative vitreoretinopathy is the most common cause of retinal detachment and visual loss in eyes with...
10.
Wilson M, Haynes E, Parsons K, Hopkins D, Robertson E, Ferguson G, et al.
Br J Haematol
. 2023 Jun;
202(4):796-800.
PMID: 37357380
Management of classical Hodgkin lymphoma in older patients is challenging due to poor tolerance of the chemotherapy regimens used in younger patients. We modified the BEACOPP regimen (bleomycin, etoposide, doxorubicin,...